Abdominal Obesity is an Independent Risk Factor in Dogs with Heart Failure
World Small Animal Veterinary Association World Congress Proceedings, 2007
Naris Thengchaisri;Wutthiwong Theerapun; Amornrate Sastravaha
Department of Companion Animal Clinical Science, Faculty of Veterinary Medicine, Kasetsart University
Bang-Khen, Bangkok

Background

The association between overall obesity and fat distribution on the present of heart disease remains unsettled. In the present study, we evaluate the association between standard and computed tomography (CT)-based measures of obesity and clinical heart disease in dog.

Design

Cross-sectional, observational study of dimension of body parts and CT obesity measures and presence of heart disease in dogs.

Subject

A survey was conducted between October 2005 to October 2006 in 47 healthy dogs and 44 adjudicated heart disease dogs at Kasetsart Veterinary Teaching Hospital, Bangkhen.

Methods

Body mass index (BMI) was calculated from body length (BL) and weight, and waist circumference (WC) and ilium wing distance (IWD) were measured. Intra-abdominal fat (IAF) and subcutaneous fat (SQF) were measured in normal (n=4) and heart disease (n=4) dogs at the levels of lumbar 4 and 5, using computed tomography.

Results

Heart disease dogs have a relative waist circumference (WC/IWD and WC-BL) higher than normal dogs. Although BMI in heart disease dogs was higher than normal dogs, but it did not reach statistical significant except in neutered female dog with heart disease. IAF and SQF were not significantly different between normal and heart disease groups.

Conclusion

Abdominal obesity, rather than overall obesity, may be another risk factor for dog with heart disease.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Naris Thengchaisri
Kasetsart University
Thailand


MAIN : Abstracts - Oral : Abdominal Obesity
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27